SCHEMBL19912355

SCHEMBL19912355

Cc1cc(-c2cc(-n3c4ccc(C)cc4c4cc(C)ccc43)c(-n3c4ccc(C)cc4c4cc(C)ccc43)cc2C#N)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
NCOA1 Q15788 1/20 0.33
HIF1A Q16665 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
TSHR P16473 1/20 0.33
SYK P43405 1/20 0.32
XDH P47989 2/20 0.32
HTR6 P50406 2/20 0.32
HRH1 P35367 1/20 0.32
KIF11 P52732 1/20 0.32
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31
PGR P06401 1/20 0.31
MAOB P27338 2/20 0.30
MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19903579 0.95 AR (0.36) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19912356 0.95 AR (0.35) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19912387 0.92 AR (0.35) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL20617048 0.92 RXRA (0.37) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19918049 0.91 KIF11 (0.33) ARSMN1; SMN2TSHRSYKXDH
SCHEMBL19912360 0.91 AR (0.36) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19917953 0.91 AR (0.35) ARSMN1; SMN2TSHRXDH
SCHEMBL19912576 0.91 AR (0.47) ARXDHPGRMAT2AKDM4E
SCHEMBL19903576 0.90 AR (0.34) ARSMN1; SMN2LMNAPOLBHTT
SCHEMBL19912425 0.89 KIF11 (0.36) ARSMN1; SMN2LMNAPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 AR 4212/4885SMN1; SMN2 4419/4885LMNA 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.